NCT06516185

Brief Summary

The purpose of this study is to evaluate the biomechanical behaviour of direct-printed and thermoformed aligners in different tooth movements, creating a biomechanical planning protocol based on a stratification of tooth movements according to the degree of predictability.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Oct 2024Jun 2026

First Submitted

Initial submission to the registry

July 8, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 23, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 22, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 12, 2024

Status Verified

June 1, 2024

Enrollment Period

1.1 years

First QC Date

July 8, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

clear aligner therapydirect-printed alignerpredictabilityshape memorystratification

Outcome Measures

Primary Outcomes (2)

  • Predictability for each type of tooth movement in patients with direct-printed aligners compared to a control group in which the movements are performed with thermoformed aligners.

    The primary outcome will be quantified through a continuous numerical variable, tooth movement efficiency or predictability (%) measured as the change between the final, intra-treatment and initial position for each of the individual movements studied, expressed as a percentage (%). The end of treatment or endpoint (E1) of this study will be established when the measurement of Little's Irregularity Index (hereafter LII) LII=0.

    Baseline and when the defined endpoint (crowding resolution, LII=0) is reached, an average of six months.

  • impact on the effectiveness and predictability of biomechanics auxiliaries compared to a control group in which movements are performed without the use of auxiliaries.

    This will be assessed by quantifying the change between the predictability with auxiliaries and without auxiliaries for each of the individual movements studied respectively, expressed as a percentage (%).

    Baseline and when the defined endpoint (crowding resolution, LII=0) is reached, an average of six months.

Secondary Outcomes (2)

  • PROMs of the patient undergoing direct-printed aligner treatment compared to the control group.

    These should be completed five times after each visit (at 24 hours, 48 hours, 72 hours, 7 days and 14 days of aligner use) until reaching the defined endpoint (crowding resolution, LII=0), an average of 6 months.

  • influence on the printed orthodontic device (POD) of varying the degree of inclination of the aligner print.

    Baseline and when the defined endpoint (crowding resolution, LII=0) is reached, an average of six months.

Study Arms (2)

Direct-printed aligner

EXPERIMENTAL

The experimental group will be treated with the aligner system fabricated by direct printing. The current protocols described in the literature and by the manufacturer for the fabrication of the printed orthodontic devices will be followed.

Device: direct-printed aligner

Thermoformed aligner

ACTIVE COMPARATOR

The control group will be treated with the thermoformed or gold standard aligner system. The established protocols for treatment with thermoformed clear aligners will be followed.

Device: thermoformed aligner

Interventions

Patients will be treated with direct-printed aligners until dental alignment is achieved.

Direct-printed aligner

Patients will be treated with thermoformed aligners until dental alignment is achieved.

Thermoformed aligner

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with malocclusion and invididual dental malpositions requiring orthodontic treatment
  • Adequate oral and periodontal health, with absence of periodontal disease, periapical infection or untreated caries.
  • No history of previous orthodontic treatment.
  • Complete permanent dentition (excluding third molars, their presence or absence being irrelevant).

You may not qualify if:

  • Altered bone metabolism (including use of antiresorptive, steroid or immunosuppressive drugs).
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Complutense University of Madrid

Madrid, 28040, Spain

RECRUITING

MeSH Terms

Conditions

Malocclusion

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Central Study Contacts

Alejandro Piñeda-Zayas

CONTACT

Alejandro Iglesias-Linares

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is designed following CONSORT guidelines as a randomized equivalence clinical trial, controlled, with two parallel arms, and single-blind.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 23, 2024

Study Start

October 22, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

December 12, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available at the end of the clinical trial in June 2026
Access Criteria
Upon request of the interested party

Locations